Genetic variation of TLR4 influences immunoendocrine stress response: An observational study in cardiac surgical patients

Critical Care

Volumn 15, Issue 2, 2011, Pages

  Koch, Alexander ^a   Hamann, Lutz ^b   Schott, Matthias ^c   Boehm, Olaf ^d   Grotemeyer, Dirk ^e   Kurt, Muhammed ^c   Schwenke, Carsten ^f   Schumann, Ralf R ^b   Bornstein, Stefan R ^g   Zacharowski, Kai ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e Centre Hospitalier du Kirchberg   (Luxembourg)

^f SCO:SSiS Statistical Consulting   (Germany)

^g UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CYTOKINE; GAMMA INTERFERON; GENOMIC DNA; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TOLL LIKE RECEPTOR 2;

ADULT; AGED; ARTICLE; DNA SCREENING; ELECTIVE SURGERY; FEMALE; GENETIC VARIABILITY; HEART SURGERY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; BLOOD; GENETICS; GENOTYPE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MIDDLE AGED; PERIOPERATIVE PERIOD; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PROSPECTIVE STUDY; TIME;

ADRENOCORTICOTROPIC HORMONE; AGED; CARDIAC SURGICAL PROCEDURES; FEMALE; GENOTYPE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-8; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; STRESS, PHYSIOLOGICAL; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 79953267783     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10130     Document Type: Article

References (73)

1. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007, 7:179-190. 10.1038/nri2038, 17318230.
2. Bornstein SR, Ziegler CG, Krug AW, Kanczkowski W, Rettori V, McCann SM, Wirth M, Zacharowski K. The role of toll-like receptors in the immune-adrenal crosstalk. Ann N Y Acad Sci 2006, 1088:307-318. 10.1196/annals.1366.027, 17192576.
3. van den Boogaard M, Ramakers BP, van Alfen N, van der Werf SP, Fick WF, Hoedemaekers CW, Verbeek MM, Schoonhoven L, van der Hoeven JG, Pickkers P. Endotoxemia-induced inflammation and the effect on the human brain. Crit Care 2010, 14:R81. 10.1186/cc9001, 2911704, 20444270.
4. Pittet YK, Berger MM, Pluess TT, Voirol P, Revelly JP, Tappy L, Chiolero RL. Blunting the response to endotoxin in healthy subjects: effects of various doses of intravenous fish oil. Intensive Care Med 2010, 36:289-295. 10.1007/s00134-009-1689-8, 19844694.
5. Clodi M, Vila G, Geyeregger R, Riedl M, Stulnig TM, Struck J, Luger TA, Luger A. Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men. Am J Physiol Endocrinol Metab 2008, 295:E686-E691. 10.1152/ajpendo.90263.2008, 18593851.
6. Bornstein SR, Zacharowski P, Schumann RR, Barthel A, Tran N, Papewalis C, Rettori V, McCann SM, Schulze-Osthoff K, Scherbaum WA, Tarnow J, Zacharowski K. Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc Natl Acad Sci USA 2004, 101:16695-16700. 10.1073/pnas.0407550101, 534518, 15546996.
7. Zacharowski K, Zacharowski PA, Koch A, Baban A, Tran N, Berkels R, Papewalis C, Schulze-Osthoff K, Knuefermann P, Zähringer U, Schumann RR, Rettori V, McCann SM, Bornstein SR. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc Natl Acad Sci USA 2006, 103:6392-6397. 10.1073/pnas.0601527103, 1458888, 16606831.
8. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000, 68:6398-6401. 10.1128/IAI.68.11.6398-6401.2000, 97725, 11035751.
9. Schroder NW, Hermann C, Hamann L, Gobel UB, Hartung T, Schumann RR. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med 2003, 81:368-372.
10. Woehrle T, Du W, Goetz A, Hsu HY, Joos TO, Weiss M, Bauer U, Brueckner UB, Marion SE. Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans. Cytokine 2008, 41:322-329. 10.1016/j.cyto.2007.12.006, 18249133, 18249133.
11. Emingil G, Berdeli A, Baylas H, Saygan BH, Gurkan A, Kose T, Atilla G. Toll-like receptor 2 and 4 gene polymorphisms in generalized aggressive periodontitis. J Periodontol 2007, 78:1968-1977. 10.1902/jop.2007.060360, 18062119.
12. Berdeli A, Emingil G, Han SB, Gurkan A, Atilla G, Kose T, Baylas H. TLR2 Arg753Gly, TLR4 Asp299Gly and Thr399Ile gene polymorphisms are not associated with chronic periodontitis in a Turkish population. J Clin Periodontol 2007, 34:551-557. 10.1111/j.1600-051X.2007.01092.x, 17555409.
13. Kutukculer N, Yeniay BS, Aksu G, Berdeli A. Arg753Gln polymorphism of the human toll-like receptor-2 gene in children with recurrent febrile infections. Biochem Genet 2007, 45:507-514. 10.1007/s10528-007-9091-0, 17554618.
14. Hamann L, Gomma A, Schroder NW, Stamme C, Glaeser C, Schulz S, Gross M, Anker SD, Fox K, Schumann RR. A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. J Mol Med 2005, 83:478-485. 10.1007/s00109-005-0643-7, 15875151.
15. Ferwerda B, McCall MB, Alonso S, Giamarellos-Bourboulis EJ, Mouktaroudi M, Izagirre N, Syafruddin D, Kibiki G, Cristea T, Hijmans A, Hamann L, Israel S, ElGhazali G, Troye-Blomberg M, Kumpf O, Maiga B, Dolo A, Doumbo O, Hermsen CC, Stalenhoef AF, van Crevel R, Brunner HG, Oh DY, Schumann RR, de la Rúa C, Sauerwein R, Kullberg BJ, van der Ven AJ, van der Meer JW, Netea MG. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci USA 2007, 104:16645-16650. 10.1073/pnas.0704828104, 2034238, 17925445.
16. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000, 25:187-191. 10.1038/76048, 10835634.
17. Schwartz DA. Inhaled endotoxin, a risk for airway disease in some people. Respir Physiol 2001, 128:47-55. 10.1016/S0034-5687(01)00264-X, 11535262.
18. Marsik C, Jilma B, Joukhadar C, Mannhalter C, Wagner O, Endler G. The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. Clin Chem 2005, 51:2178-2180. 10.1373/clinchem.2005.051649, 16244296.
19. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003, 75:S715-S720. 10.1016/S0003-4975(02)04701-X, 12607717.
20. Rinder C. Cellular inflammatory response and clinical outcome in cardiac surgery. Curr Opin Anaesthesiol 2006, 19:65-68. 10.1097/01.aco.0000192773.86656.bf, 16547435.
21. Velissaris T, Tang AT, Murray M, Mehta RL, Wood PJ, Hett DA, Ohri SK. A prospective randomized study to evaluate stress response during beating-heart and conventional coronary revascularization. Ann Thorac Surg 2004, 78:506-512. 10.1016/S0003-4975(03)01360-2, 15276508.
22. Roth-Isigkeit A, Dibbelt L, Schmucker P, Seyfarth M. The immune-endocrine interaction varies with the duration of the inflammatory process in cardiac surgery patients. J Neuroendocrinol 2000, 12:546-552. 10.1046/j.1365-2826.2000.00484.x, 10844583.
23. Roth-Isigkeit AK, Schmucker P. Postoperative dissociation of blood levels of cortisol and adrenocorticotropin after coronary artery bypass grafting surgery. Steroids 1997, 62:695-699. 10.1016/S0039-128X(97)00069-X, 9366007.
24. Mitchell JD, Grocott HP, Phillips-Bute B, Mathew JP, Newman MF, Bar-Yosef S. Cytokine secretion after cardiac surgery and its relationship to postoperative fever. Cytokine 2007, 38:37-42. 10.1016/j.cyto.2007.04.009, 17572096.
25. Hamann L, Hamprecht A, Gomma A, Schumann RR. Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the Toll-like receptor -2, -4, and -9 genes. J Immunol Methods 2004, 285:281-291. 10.1016/j.jim.2003.12.005, 14980441.
26. Paramonova I, Haase M, Mülders-Opgenoorth B, Ansurudeen-Rafi I, Bornstein SR, Papewalis C, Schinner S, Schott M, Scherbaum WA, Willenberg HS. The effects of the endothelium on adrenal steroidogenesis and growth are mainly mediated by proteins other than endothelin-1. Horm Metab Res 2010, 42:840-845. 10.1055/s-0030-1265129, 20839150.
27. Koch A, Zacharowski K, Boehm O, Stevens M, Lipfert P, von Giesen HJ, Wolf A, Freynhagen R. Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients. Inflamm Res 2007, 56:32-37. 10.1007/s00011-007-6088-4, 17334668.
28. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993, 55:552-559. 10.1016/0003-4975(93)91048-R, 8431082.
29. Koch A, Zacharowski P, Boehm O, Zacharowski K. Innate immunity, coagulation and surgery. Front Biosci 2009, 14:2970-2982. 10.2741/3427, 19273249.
30. Taylor KM, Jones JV, Walker MS, Rao S, Bain WH. The cortisol response during heart-lung bypass. Circulation 1976, 54:20-25.
31. Walker WF. Adrenal response to cardiac surgery. Proc R Soc Med 1965, 58:1015-1017. 1899044, 5852672.
32. Rasmussen BS, Sollid J, Knudsen L, Christensen T, Toft E, Tonnesen E. The release of systemic inflammatory mediators is independent of cardiopulmonary bypass temperature. J Cardiothorac Vasc Anesth 2007, 21:191-196. 10.1053/j.jvca.2006.02.030, 17418730.
33. Roth-Isigkeit A, Dibbelt L, Eichler W, Schumacher J, Schmucker P. Blood levels of atrial natriuretic peptide, endothelin, cortisol and ACTH in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass. J Endocrinol Invest 2001, 24:777-785.
34. Vogeser M, Groetzner J, Kupper C, Briegel J. The serum cortisol:cortisone ratio in the postoperative acute-phase response. Horm Res 2003, 59:293-296. 10.1159/000070628, 12784094.
35. Roth-Isigkeit A, Ocklitz E, Bruckner S, Ros A, Dibbelt L, Friedrich HJ, Gehring H, Schmucker P. Development and evaluation of a video program for presentation prior to elective cardiac surgery. Acta Anaesthesiol Scand 2002, 46:415-423. 10.1034/j.1399-6576.2002.460415.x, 11952443.
36. Calzia E, Koch M, Stahl W, Radermacher P, Brinkmann A. Stress response during weaning after cardiac surgery. Br J Anaesth 2001, 87:490-493. 10.1093/bja/87.3.490, 11517136.
37. Zaugg M, Tagliente T, Lucchinetti E, Jacobs E, Krol M, Bodian C, Reich DL, Silverstein JH. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 1999, 91:1674-1686. 10.1097/00000542-199912000-00020, 10598610.
38. Lacoumenta S, Yeo TH, Paterson JL, Burrin JM, Hall GM. Hormonal and metabolic responses to cardiac surgery with sufentanil-oxygen anaesthesia. Acta Anaesthesiol Scand 1987, 31:258-263. 10.1111/j.1399-6576.1987.tb02562.x, 3033969.
39. von Bormann B, Sturm G, Kling D, Scheld HH, Boldt J, Hempelmann G. [Significance of endocrine parameters of stress]. Anaesthesist 1985, 34:280-286.
40. Bornstein SR, Engeland WC, Ehrhart-Bornstein M, Herman JP. Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab 2008, 19:175-180. 10.1016/j.tem.2008.01.009, 18394919.
41. Dimopoulou I, Tzanela M, Vassiliadi D, Mavrou I, Kopterides P, Orfanos S, Kotanidou A, Kontogiannopoulou S, Vasdekis S, Tsangaris I, Armaganidis A, Macheras A, Ilias I, Kostopanagiotou G, Tsagarakis S. Pituitary-adrenal responses following major abdominal surgery. Hormones (Athens) 2008, 7:237-242.
42. Meyer WJ, Smith EM, Richards GE, Cavallo A, Morrill AC, Blalock JE. In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear leukocytes from normal and ACTH-deficient individuals. J Clin Endocrinol Metab 1987, 64:98-105. 10.1210/jcem-64-1-98, 2430992.
43. Jones CT, Edwards AV. Release of adrenocorticotrophin from the adrenal gland in the conscious calf. J Physiol 1990, 426:397-407. 1189895, 2172517.
44. Crofford LJ, Sano H, Karalis K, Webster EL, Goldmuntz EA, Chrousos GP, Wilder RL. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J Clin Invest 1992, 90:2555-2564. 10.1172/JCI116150, 443415, 1281840.
45. Ekman R, Servenius B, Castro MG, Lowry PJ, Cederlund AS, Bergman O, Sjogren HO. Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes. J Neuroimmunol 1993, 44:7-13. 10.1016/0165-5728(93)90262-W, 8496339.
46. Engeland WC. Functional innervation of the adrenal cortex by the splanchnic nerve. Horm Metab Res 1998, 30:311-314. 10.1055/s-2007-978890, 9694555.
47. Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA, Pfeiffer EF, Holst JJ. Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner. Endocrinology 1990, 127:900-906. 10.1210/endo-127-2-900, 2373060.
48. Henzen C, Kobza R, Schwaller-Protzmann B, Stulz P, Briner VA. Adrenal function during coronary artery bypass grafting. Eur J Endocrinol 2003, 148:663-668. 10.1530/eje.0.1480663, 12773139.
49. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 1991, 128:37-44. 10.1210/endo-128-1-37, 1846105.
50. Silverman MN, Miller AH, Biron CA, Pearce BD. Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection. Endocrinology 2004, 145:3580-3589. 10.1210/en.2003-1421, 15044377.
51. Crispino S, Lissoni P, Ardizzoia A, Barni S, Rovelli F, Tancini G. Effects of granulocyte-macrophage colony stimulating factor on cortisol, growth hormone, prolactin and melatonin in cancer patients (short communication). J Biol Regul Homeost Agents 1992, 6:142-144.
52. Vermes I, Beishuizen A. The hypothalamic-pituitary-adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab 2001, 15:495-511. 10.1053/beem.2001.0166, 11800520.
53. Lipiner-Friedman D, Sprung CL, Laterre PF, Weiss Y, Goodman SV, Vogeser M, Briegel J, Keh D, Singer M, Moreno R, Bellissant E, Annane D, . Corticus Study Group Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med 2007, 35:1012-1018. 10.1097/01.CCM.0000259465.92018.6E, 17334243, Corticus Study Group.
54. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003, 348:727-734. 10.1056/NEJMra020529, 12594318.
55. Bornstein SR. Predisposing factors for adrenal insufficiency. N Engl J Med 2009, 360:2328-2339. 10.1056/NEJMra0804635, 19474430.
56. Briegel J, Sprung CL, Annane D, Singer M, Keh D, Moreno R, Möhnle P, Weiss Y, Avidan A, Brunkhorst FM, Fiedler F, Vogeser M, . CORTICUS Study Group Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock. Intensive Care Med 2009, 35:2151-2156. 10.1007/s00134-009-1627-9, 19760208, CORTICUS Study Group.
57. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, Tsagarakis S, Singer M, Chrousos GP, Zaloga G, Bokhari F, Vogeser M, . American College of Critical Care Medicine Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008, 36:1937-1949. 10.1097/CCM.0b013e31817603ba, 18496365, American College of Critical Care Medicine.
58. Kenyon N. Defining adrenal insufficiency in septic shock. Crit Care Med 2003, 31:321-323. 10.1097/00003246-200301000-00059, 12545044.
59. Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002, 186:1522-1525. 10.1086/344893, 12404174.
60. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002, 162:1028-1032. 10.1001/archinte.162.9.1028, 11996613.
61. Child NJ, Yang IA, Pulletz MC, Courcy-Golder K, Andrews AL, Pappachan VJ, Holloway JW. Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem Soc Trans 2003, 31:652-653. 10.1042/BST0310652, 12773175.
62. Bown MJ, Nicholson ML, Bell PR, Sayers RD. Cytokines and inflammatory pathways in the pathogenesis of multiple organ failure following abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2001, 22:485-495. 10.1053/ejvs.2001.1522, 11735196.
63. Kumpf O, Hamann L, Schlag PM, Schumann RR. Pre- and postoperative cytokine release after in vitro whole blood lipopolysaccharide stimulation and frequent toll-like receptor 4 polymorphisms. Shock 2006, 25:123-128. 10.1097/01.shk.0000190823.44030.e6, 16525349.
64. Calvano JE, Bowers DJ, Coyle SM, Macor M, Reddell MT, Kumar A, Calvano SE, Lowry SF. Response to systemic endotoxemia among humans bearing polymorphisms of the Toll-like receptor 4 (hTLR4). Clin Immunol 2006, 121:186-190. 10.1016/j.clim.2006.05.012, 16829202.
65. Borgermann J, Friedrich I, Scheubel R, Kuss O, Lendemans S, Silber RE, Kreuzfelder E, Flohe S. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass. Thorac Cardiovasc Surg 2007, 55:24-31. 10.1055/s-2006-924621, 17285470.
66. Kim OY, Monsel A, Bertrand M, Coriat P, Cavaillon JM, Adib-Conquy M. Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation. Crit Care 2010, 14:R61. 10.1186/cc8959, 2887183, 20385017.
67. Hranjec T, Swenson BR, Dossett LA, Metzger R, Flohr TR, Popovsky KA, Bonatti HJ, May AK, Sawyer RG. Diagnosis-dependent relationships between cytokine levels and survival in patients admitted for surgical critical care. J Am Coll Surg 2010, 210:833-836. 10.1016/j.jamcollsurg.2009.12.042, 2861048, 20421061.
68. Dehus O, Bunk S, von Aulock S, Hermann C. IL-10 release requires stronger toll-like receptor 4-triggering than TNF: a possible explanation for the selective effects of heterozygous TLR4 polymorphism Asp(299)Gly on IL-10 release. Immunobiology 2008, 213:621-627. 10.1016/j.imbio.2008.03.001, 18950592.
69. von Aulock S, Schröder NW, Gueinzius K, Traub S, Hoffmann S, Graf K, Dimmeler S, Hartung T, Schumann RR, Hermann C. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J Infect Dis 2003, 188:938-943. 10.1086/378095, 12964127.
70. Smith EM, Cadet P, Stefano GB, Opp MR, Hughes TK. IL-10 as a mediator in the HPA axis and brain. J Neuroimmunol 1999, 100:140-148. 10.1016/S0165-5728(99)00206-4, 10695724.
71. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011, 364:656-665. 10.1056/NEJMra0910283, 21323543.
72. Kuhlicke J, Frick JS, Morote-Garcia JC, Rosenberger P, Eltzschig HK. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One 2007, 2:e1364. 10.1371/journal.pone.0001364, 2147045, 18159247.
73. Koch A, Hamann L, Schumann R, Schwenke C, Bornstein S, Zacharowski K. Single nucleotide polymorphism (SNP) of Toll-like receptor (TLR)4 influences hypothalamic-pituitary-adrenal (HPA) axis regulation in patients with postoperative systemic inflammation. Inflamm Res 2010, 59 Suppl 1:S103.